The following articles (labelled with PubMed ID or TBD) are for your review| PMID | Article Title | Published | Deposition |
|---|
| 33756124 |
Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors. |
05-MAY-2021 |
20-AUG-2022 |
| 33198466 |
Discovery of Potent and Brain-Penetrant GPR52 Agonist that Suppresses Psychostimulant Behavior. |
25-NOV-2020 |
25-MAR-2022 |
| 32567857 |
Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT |
23-JUL-2020 |
13-AUG-2021 |
| 32631520 |
Discovery of phenanthridine analogues as novel chemical probes disrupting the binding of DNA to ?FosB homodimers and ?FosB/JunD heterodimers. |
15-AUG-2020 |
13-AUG-2021 |
| 32297742 |
Mechanism of Action of an EPAC1-Selective Competitive Partial Agonist. |
14-MAY-2020 |
11-AUG-2021 |
| 31098001 |
Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists. |
09-MAY-2019 |
28-FEB-2021 |
| 32255647 |
Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation. |
28-MAY-2020 |
25-FEB-2021 |
| 31220676 |
Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer. |
15-SEP-2019 |
22-FEB-2021 |
| 32340447 |
Synthesis and Biochemical Evaluation of Noncyclic Nucleotide Exchange Proteins Directly Activated by cAMP 1 (EPAC1) Regulators. |
28-MAY-2020 |
20-FEB-2021 |
| 29100797 |
Structure-activity relationships of 2-substituted phenyl-N-phenyl-2-oxoacetohydrazonoyl cyanides as novel antagonists of exchange proteins directly activated by cAMP (EPACs). |
01-DEC-2017 |
15-AUG-2020 |
| 28283242 |
Exchange proteins directly activated by cAMP (EPACs): Emerging therapeutic targets. |
15-APR-2017 |
15-AUG-2020 |
| 29649741 |
Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation. |
10-MAY-2018 |
15-AUG-2020 |
| 28195723 |
Drug Discovery Targeting Bromodomain-Containing Protein 4. |
08-JUN-2017 |
10-JAN-2020 |
| 28399451 |
Identification of novel 2-(benzo[d]isoxazol-3-yl)-2-oxo-N-phenylacetohydrazonoyl cyanide analoguesas potent EPAC antagonists. |
07-JUL-2017 |
12-OCT-2019 |
| 27190593 |
Functionalized N,N-Diphenylamines as Potent and Selective EPAC2 Inhibitors. |
18-MAY-2016 |
13-SEP-2017 |
| 26151319 |
Structure-Activity Relationship Studies of Substituted 2-(Isoxazol-3-yl)-2-oxo-N'-phenyl-acetohydrazonoyl Cyanide Analogues: Identification of Potent Exchange Proteins Directly Activated by cAMP (EPAC) Antagonists. |
13-AUG-2015 |
26-OCT-2016 |
| 24831826 |
Small molecule inhibitors targeting activator protein 1 (AP-1). |
28-AUG-2014 |
20-MAR-2016 |
| 24256330 |
Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC). |
08-MAY-2014 |
08-FEB-2015 |
| 23286832 |
Identification and characterization of small molecules as potent and specific EPAC2 antagonists. |
15-FEB-2013 |
24-SEP-2013 |
| 22607683 |
5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP. |
29-MAY-2012 |
07-FEB-2013 |
| 18620864 |
Novel inhibitors of anthrax edema factor. |
11-AUG-2008 |
11-JAN-2010 |
| 17826998 |
Synthesis and screening of 3-substituted thioxanthen-9-one-10,10-dioxides. |
01-OCT-2007 |
10-NOV-2009 |
Search and Browse
